Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01693068
Title Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors EMD Serono
Indications

skin melanoma

Therapies

Dacarbazine

Pimasertib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST